Plazomicin
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: ACHN-490, plazomicin sulfate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Plazomicin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 2018. Recorded indications include Urinary tract infectious disease.
- Approval status: ofm (first approved 2018 by the FDA).
- Indications: Urinary tract infectious disease.
- ATC code: J01GB14 (Other aminoglycosides).
- Molecular formula: C25H48N6O10; molecular weight 592.69 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Urinary tract infectious disease
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2018-06-25 | FDA | — | ACHAOGEN INC |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01GB14 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › AMINOGLYCOSIDE ANTIBACTERIALS › Other aminoglycosides |
Pharmacogenomics
Drug-label and guideline annotations from PharmGKB and CPIC.
- FDA label: MT-RNR1 · Actionable PGx
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Plazomicin is on its molecule page.
| Molecular formula | C25H48N6O10 |
|---|---|
| Molecular weight | 592.69 g/mol |
| CAS number | 1154757-24-0 |
| InChIKey | IYDYFVUFSPQPPV-PEXOCOHZSA-N |
| PubChem CID | 42613186 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Plazomicin used for?
DrugCentral lists the following indications for Plazomicin: Urinary tract infectious disease.
When was Plazomicin first approved?
Plazomicin was first approved by the FDA in 2018.
What is the chemical formula of Plazomicin?
Plazomicin has the molecular formula C25H48N6O10 and a molecular weight of 592.69 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5287 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1650559 — compound record and bioactivity
- PubChem CID 42613186 — chemical identifiers
- DrugBank DB12615 — drug record
- FDA UNII LYO9XZ250J — substance identity
- DailyMed: FDA labels for Plazomicin — current prescribing information (label search)
- PharmGKB / CPIC — pharmacogenomic label annotations
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.